Defensins: the Case for Their Use against Mycobacterial Infections

Human tuberculosis remains a huge global public health problem with an estimated 1/3rd of the population being infected. defensins are antibacterial cationic peptides produced by a number of cell types,most notably neutrophil granulocytes and epithelial cells. all three defensin types (α-,β-,and θ-defensins) have antibacterial activities,mainly through bacterial membrane permeabilization. defensins are effective against gram-negative and gram-positive bacteria including mycobacteria and are active both intra- and extracellularly. mycobacterial resistance has never been demonstrated although the mprf gene encoding resistance in staphylococcus aureus is present in the mycobacterium tuberculosis genome. in addition to their antibacterial effect,defensins are chemoattractants for macrophages and neutrophils. there are many cases for their use for therapy or prophylaxis in tuberculosis as well. in conclusion,we propose that there is considerable scope and potential for exploring their use as therapeutic/prophylactic agents and more comprehensive survey of defensins from different species and their bioactivity is timely. � 2016 haodi dong et al.